đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
Study to assess the effect of Selumetinib \[AZD6244; ARRY-142886\] \[Hyd-Su...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02056392
Treatments Being Tested
This is a phase II, multicenter, randomised, parallel, double-blind, placeb...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-08-31
Trial ID
NCT05825365
Treatments Being Tested
The purpose of this study is to assess the efficacy of selumetinib in combi...
Status
Active Not Recruiting
Location
Research Site
Start Date
2013-09-25
Trial ID
NCT01933932
Treatments Being Tested
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Status
Completed
Location
Universitair Ziekenhuis Gent
Start Date
2010-08
Trial ID
NCT01160718
Treatments Being Tested
The purpose of this study is to treat patients with locally advanced or met...
Status
Completed
Location
Research Site
Start Date
2012-12-18
Trial ID
NCT01750281
Treatments Being Tested
This phase II trial studies how well iodine I-131 works with or without sel...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-05-04
Trial ID
NCT02393690
Treatments Being Tested
Selumetinib therapy in patients with metastatic uveal melanoma....
Status
Completed
Location
Research Site
Start Date
2014-04
Trial ID
NCT01974752
Treatments Being Tested
The study is designed to evaluate the clinical efficacy, safety and tolerab...
Status
Terminated
Location
Research Site
Start Date
2013-08-27
Trial ID
NCT01843062
Treatments Being Tested
The purpose of this study is to compare the efficacy of AZD6244 in combinat...
Status
Completed
Location
Research Site
Start Date
2009-04-20
Trial ID
NCT00890825
To assess the efficacy in terms of overall survival of AZD6244 in combinati...
Status
Completed
Location
Research Site
Start Date
2009-07
Trial ID
NCT00936221
Treatments Being Tested